LampHill Letter: January 2026
This month, one evidence guide from each pillar: Longevity, Cardiovascular, Brain, Muscle, Nutrition, Supplements, Biomarkers, Genetics.
This month covers two of the most contested topics in evidence-based nutrition, a metabolite most cardiologists have never heard of, and a genetic variant that reshapes Alzheimer's risk before symptoms appear. There is also a longevity compound that extends lifespan in male mice without feminizing effects, and a framework for training toward specific physical goals at age 88. The cell biology and fiber articles are quieter but grounded in unusually solid evidence.
This month's reading
Longevity. The cell's internal recycling system is tightly regulated, but what controls it and what happens when it fails? Autophagy
Cardiovascular. Metabolic poison or misunderstood staple: what does the evidence say about seed oils? Are seed oils uniquely harmful, the omega-6 debate
Brain. Alzheimer's may involve a measurable collapse in brain energy metabolism long before memory loss becomes obvious. Alzheimer's disease
Muscle. The question is not whether you will be healthy at 88, but whether you can still carry groceries upstairs. Centenarian decathlon
Nutrition. The evidence for eating more fiber is described here as about as solid as nutritional science gets. Dietary fiber
Supplements. A naturally occurring estradiol variant extends lifespan in male mice without the feminizing effects people assume. 17α-estradiol
Biomarkers. Researchers hunting cardiovascular risk beyond LDL found a niacin metabolite most clinicians have never measured. 4PY (niacin terminal metabolite)
Genetics. The variant you inherited shapes your Alzheimer's risk and your cholesterol handling in ways that are not yet fully separable. APOE4
Every claim in these guides links to its source. The full standard is on our about page.